Search Results - Nadege Gitego

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis

    Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis by Nadege Gitego, Bogos Agianian, Oi Wei Mak, Vasantha Kumar MV, Emily H. Cheng, Evripidis Gavathiotis

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Inhibitors of BRAF dimers using an allosteric site

    Inhibitors of BRAF dimers using an allosteric site by Xiomaris M. Cotto-Rios, Bogos Agianian, Nadege Gitego, Emmanouil Zacharioudakis, Orsi Giricz, Yang Wu, Yiyu Zou, Amit Verma, Poulikos I. Poulikakos, Evripidis Gavathiotis

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin

    Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin by Dan Y. Gui, Lucas B. Sullivan, Alba Luengo, Aaron M. Hosios, Lauren N. Bush, Nadege Gitego, Shawn M. Davidson, Elizaveta Freinkman, Craig J. Thomas, Matthew G. Vander Heiden

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer

    Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer by Andrea López, Denis E. Reyna, Nadege Gitego, Felix Kopp, Hua Zhou, Miguel A. Miranda-Román, Lars Ulrik Nordstrøm, Swathi-Rao Narayanagari, Ping Chi, Eduardo Vilar, Aristotelis Tsirigos, Evripidis Gavathiotis

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine

    ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine by Nora E. Rahmani, Nandini Ramachandra, Srabani Sahu, Nadege Gitego, Andrea López, Kith Pradhan, Tushar D. Bhagat, Shanisha Gordon-Mitchell, Bianca Rivera-Peña, Mohammad Hossein Kazemi, K. Visweswara Rao, Orsi Giricz, Shahina B. Maqbool, Raul Olea, Yongmei Zhao, Jinghang Zhang, Hamid Dolatshad, Vickram Tittrea, Dharamveer Tatwavedi, Shalini Singh, Juseong Lee, Tianyu Sun, Ulrich Steidl, Aditi Shastri, Daichi Inoue, Omar Abdel‐Wahab, Andrea Pellagatti, Evripidis Gavathiotis, Jacqueline Boultwood, Amit Verma

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

    North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies by Urvi A. Shah, Elaine Y. Chung, Orsi Giricz, Kith Pradhan, Keisuke Kataoka, Shanisha Gordon-Mitchell, Tushar D. Bhagat, Yun Mai, Yongqiang Wei, Elise Ishida, Gaurav S. Choudhary, Ancy Joseph, Ronald E. Rice, Nadege Gitego, Crystall Parrish, Matthias Bartenstein, Swati Goel, Ioannis Mantzaris, Aditi Shastri, Olga Derman, Adam F. Binder, Kira Gritsman, Noah Kornblum, Ira Braunschweig, Chirag Bhagat, Jeff Hall, Armin Graber, Lee Ratner, Yanhua Wang, Seishi Ogawa, Amit Verma, B. Hilda Ye, Murali Janakiram

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: